Tag: hope

  • A glimmer of hope at UNC clinic re: long COVID

    A glimmer of hope at UNC clinic re: long COVID

    By Thomas Goldsmith

    Tony Marks in Pinehurst and Brooke Keaton in Charlotte both lived orderly, productive lives two years ago. That was clearly reflected in their steady jobs and close family ties.

    However, their experiences with the long-term effects of infection with the COVID-19 virus have touched and in many cases devastated nearly every other aspect of each of their days.

    Marks and Keaton don’t know each other, but both have worked with John M. Baratta, who practices physical medicine and rehabilitation at the University of North Carolina COVID Recovery Clinic. There, Baratta and his colleagues attempt to explore several paths out of these lingering, disabling after-effects of the pandemic.

    “I haven’t had a day in over a year and a half that I have not hurt, that I have not been tired, that my hands just don’t feel like they have arthritis,” Marks, 55, a software executive, said during a physical therapy session at the clinic. “I just can’t explain how bad I just physically hurt, on a day-to-day basis, and there’s the fatigue, and so I know there’s gotta be something else, right? And that’s why I want to do this so badly.”

    As Marks battles the lingering effects of COVID, he faces unpredictable limits on his working days. Keaton struggles with her symptoms so much that she has lost her job as a preschool teacher.

    However, in the larger picture emerging from the UNC clinic and others, there are signs that help may be on the way for the patients known as COVID “long haulers” — aid in the form of new research, promising treatments, and evolving approaches to therapy.

    New research holds hope

    Approaches monitored at the UNC clinic include new hard science about microclots that may lie at the heart of some of long COVID’s symptoms, a potentially game-changing analysis introduced by South African researcher, Resia Pretorius. 

    Dr. John M. Baratta, founder and co-director of the UNC Health COVID Recovery Clinic. Credit: Thomas Goldsmith

    “Her lab has demonstrated that there are circulating microclots in the blood of many people with long COVID,” Baratta explained during an interview at the Chapel Hill-based clinic. “These clots don’t necessarily block blood vessels causing stroke or heart attack. What these microclots do is trap inflammatory molecules and they prevent the breakdown of some of the inflammation. 

    “So these circulating microclots can cause this persistent inflammatory process. And they’ve actually, in some early clinical research, been trying to anticoagulate patients in an attempt to break down the microclots and some of their early data suggests favorable results.” 

    The theory of microclots’ role in the disease has created excitement as an example of a new direction, even though Pretorius’s findings were based on a relatively small sample of patients and separate research found lower levels of microclotting in the vessels of other long COVID patients. 

    It’s too early to know whether Pretorius’s findings will be replicated on a large scale, Baratta said, but her findings show the kind of progress that will be necessary to advance the treatment of long COVID.

    Known internationally before her research on long COVID, Pretorius gave the keynote speech at a symposium on approaches to long COVID presented by UNC in Greensboro in May.

    How many people have long COVID?

    A U.S. Government Accountability Office estimate found that more than seven million people, and as many as 23 million people nationally have long COVID.

    A recent study of more than 100,000 people in Scotland, regarded as authoritative because it relied on National Health Service data, found that 6 percent of people diagnosed with acute COVID-19 had not recovered at all and 42 percent had only partially recovered.

    How to avoid energy deficits

    Closer to home, therapists at the clinic give advice to patients on rationing their energy by comparing it to a balance on a credit card, a finite amount that must be carefully monitored lest it fall into a steep deficit. UNC clinic staffer Courtney Matrunick, who holds a doctorate in physical therapy, explained the theory about pacing to Marks during a visit to the Chapel Hill clinic. She told him that he will exhaust his energy balance more quickly as a COVID long hauler.

    “Every morning you’re waking up and getting $100. It may not feel like you’re getting $100, but you’re getting this $100,” Matrunick said during a therapy session in a clinic examination room. “But you’re using more. So now you’re in a deficit. Right? So the next morning — and this is just super simplified — you have $100 and you use $150. You’re in a $50 deficit already.

    “Then the next day you wake up and you don’t even have the energy to pay off that bill. But you still have to survive. You still have to eat, you still have to do everything, but you feel like, ‘I can’t get out of bed,’” she said. “And that’s because you literally have used everything.”

    Matrunick said that’s often when a long COVID patient ends up needing to stay in bed for a couple of days to catch up.

    Matrunick cites California physical therapist and academic Todd Davenport as her source for the credit-card analogy. More specialized information is available on this podcast. Davenport recommends carefully tailoring activities and any exercise to avoid making symptoms worse after exertion.

    Oxygen deprivation may cause long-haul symptoms

    Researcher Pretorius asserts that some clinicians have made incorrect diagnoses in cases of long COVID because most tests don’t pick up on the presence of inflammation hidden within the microclots she’s studying.

    “Many people feel that they go to a clinician and they are misdiagnosed,” Pretorius said during a video interview with the PolyBio Research Foundation.  “Many of the typical laboratory blood-type analyses will not pick up any differences in inflammatory markers. And the patient has become very desperate as the condition is ascribed to a psychological issue.”

    In Pretorius’s research, two infusions of the anticoagulant drug succeeded in dissolving the microclots. This allowed treatment of the inflammation that can cause damage to blood vessels and prevent oxygen – known as hypoxia – from reaching cells.

    “And if you look at the (long COVID) symptoms closely, it all comes back to a hypoxia of certain organ systems — whether it’s the muscle not getting enough oxygen, whether it’s liver damage, whether it’s brain fog concentration issues,” Pretorius said. “One can all bring it back to a reason why the symptoms might happen, because of oxygen deprivation to certain areas.”

    ‘Where’s the part where you apologize?’

    Keaton, now 42, had been a go-to teacher, mom to two girls, a wife and someone deeply involved in church with a broad community of family and friends, when she was diagnosed with COVID-19 in December 2020. 

    “I was a fun teacher,” Keaton said. “They knew I played music and I would say, ‘We will dance! We will have a party on the playground!’

    Charlotte resident Brooke Keaton has dealt with long COVID symptoms such as fatigue and memory issues for two years. She’s seen with husband Jared and daughters Bria, 4, and Jaren, 12. Submitted photo.

    “And now I can’t even walk down the steps down to my kitchen without becoming short of breath. Even now having this conversation with you, I feel myself being short of breath.”

    During a phone call from Charlotte, Keaton told of how missed diagnoses caused problems in her now yearslong effort to address her post-acute COVID symptoms. She said she’s heard of similar experiences during online discussions as a part of a group of Black women facing long COVID.

    Keaton described an attempt to steer her on an unproductive path by a doctor who seemed determined to act on a particular diagnosis.

    “I went in explaining to her the fatigue, the memory loss, the brain fog, the issue with the numbness in my hands and my feet, and feeling vibrations,” Keaton said. “And she looked at me and she’s like, ‘I think we need to test you for sleep apnea. Has that ever been a concern?’”

    Researchers have found a high incidence of undiagnosed sleep apnea in African Americans, but Keaton pointed out that her husband could attest to the fact that she didn’t even snore. 

    “And her whole thing was like, ‘I think all of this is because you have sleep apnea,’” Keaton said. So Keaton spent money on testing at home and at the physician’s office, both of which indicated she did not have sleep apnea. 

    “And she just kind of left it there. I’m like, ‘So we determined I don’t have sleep apnea. What can we do about everything else?’” Keaton said. In response, the physician gave her pointers on how to get better sleep at night. 

    “So fast forward: ‘Where’s the part where you apologize to me for making an assumption, you know?’”

    Adding insult to the entire process, Keaton has found her insurance coverage did not cover certain treatments and therapies that were otherwise recommended.

  • Opinion | When Hope Hinges on an Unapproved Drug

    Opinion | When Hope Hinges on an Unapproved Drug

    Instead, frequently the most important hurdles, as the Forbes relatives noticed, are whether or not the drug enterprise has an expanded-obtain application for a unique drug and, if it does, no matter if it approves the request. There is no prerequisite for organizations to report how several requests they acknowledge, however some larger drug companies make this information and facts public.

    Perhaps far more essential, it’s unidentified to what extent families’ media strategies influence these choices. This is what difficulties Arthur Caplan, a professor of bioethics at New York University’s Grossman College of Drugs. “If you have means, then you employ PR individuals, you construct your possess web-site, and you have a rather very good probability of guilting or shaming the business into supplying a little something to you,” he informed me. “I understand why people today do it, but it’s barely an equitable process.”

    Dr. Caplan has pioneered a attainable answer. Operating with Janssen Prescription drugs, a portion of Johnson & Johnson, he heads an advisory committee of doctors, ethicists and community associates who assess these requests and then build a suggestion for the drug organization. Much like the U.S. procedure for organ allocation, which Dr. Caplan also served establish, this committee aims to ensure a truthful allocation of a constrained source. Drug corporations should really not be swayed to say indeed by the most sympathetic photos or pushed to say no for the reason that of a problem that a adverse end result could influence client confidence in a drug. As an alternative, the committee applies dependable conditions to each and every anonymous possible recipient and renders a final decision dependent on clinical factors rather than the pathos of a own tale, prosperity or media prominence.

    This is a get started, particularly when coupled with better tracking of outcomes and enhanced schooling for clinicians about how to enroll their sufferers in clinical trials and navigate expanded accessibility if those trials aren’t a risk. A law firm by instruction, Ms. Forbes did most of this navigation and advocacy on her very own, but there are a lot of family members for whom that would not be attainable. And when clinicians’ time is a minimal source, how a great deal of this approach can they realistically just take on for a drug not nonetheless proved to perform?

    That is the question powering so a lot of this discussion. How significantly do we go when the option is demise? And what is sacrificed in the procedure? “You’re holding out hope that you may be that scarce a single, that if you can just continue to be alive prolonged more than enough for the future drug, that could possibly adjust matters,” Ms. Forbes informed me, reflecting on all those final weeks.

    Even though her spouse by no means did obtain the expanded-obtain drug, she does not regret that they devoted so significantly of their remaining time and energy to pursuing it. They considered that this medication would perform, she reported, but they ended up also equipped to look at a truth in which Mr. Forbes did not dwell to see it.

    “Despite how it all ended, it was very good for Michael to sense positive and hopeful,” she mentioned. “It was quite great for me, due to the fact there was no stone unturned.” That is not the kind of victory they preferred, but it is something.

  • Can CBD really prevent COVID-19 infection? Scientists hope to find out.

    Can CBD really prevent COVID-19 infection? Scientists hope to find out.

    Cannabidiol (CBD), an energetic component in hashish, may well assistance block infection with the virus that brings about COVID-19.

    But really don’t go fall a bunch of cash on CBD oils at your nearby dispensary: The attainable influence still requirements to be tested in humans. (And absolutely will not smoke marijuana to protect against coronavirus an infection.) Even if the findings do maintain up, they use to the form of health-related-grade, Food items and Drug Administration (Food and drug administration)-authorised CBD utilised to deal with seizure disorders, not the very low-potency things readily available to shoppers.